Evidence map›Paper›PMID 26000327›Full record

ArticleAnnals of clinical and translational neurology2015

Epilepsy, cognitive deficits and neuroanatomy in males with ZDHHC9 mutations.

Kate Baker, Duncan E Astle, Gaia Scerif, Jessica Barnes, Jennie Smith, Georgina Moffat, Jonathan Gillard, Torsten Baldeweg, F Lucy Raymond

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Regulatory effects of post-translational modifications on zDHHCThe Journal of biological chemistry · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kate BakerDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge Cambridge, United Kingdom ; MRC Cognitive and Brain Sciences Unit Cambridge, United Kingdom.
Duncan E AstleMRC Cognitive and Brain Sciences Unit Cambridge, United Kingdom.
Gaia ScerifDepartment of Experimental Psychology, University of Oxford Oxford, United Kingdom.
Jessica BarnesMRC Cognitive and Brain Sciences Unit Cambridge, United Kingdom.
Jennie SmithSpeech and Language Therapy Team, Cleft.Net.East, Addenbrookes Hospital Cambridge, United Kingdom.
Georgina MoffatSpeech and Language Therapy Team, Cleft.Net.East, Addenbrookes Hospital Cambridge, United Kingdom.
Jonathan GillardDepartment of Radiology, University of Cambridge Cambridge, United Kingdom.
Torsten BaldewegDevelopmental Neuroscience Programme, Institute of Child Health, University College London London, United Kingdom.
F Lucy RaymondDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge Cambridge, United Kingdom.
University of Cambridge · GBAddenbrooke's Hospital · GBMRC Cognition and Brain Sciences Unit · GBUniversity College London · GBUniversity of Oxford · GB

Funding

Medical Research Council G1002276Medical Research Council MC_UP_A060_1103Wellcome Trust 100140
6 · The paper itself

Abstract

objectiveSystematic investigation of individuals with intellectual disability after genetic diagnosis can illuminate specific phenotypes and mechanisms relevant to common neurodevelopmental disorders. We report the neurological, cognitive and neuroanatomical characteristics of nine males from three families with loss-of-function mutations in ZDHHC9 (OMIM #300799).

methodsAll known cases of X-linked intellectual disability (XLID) due to ZDHHC9 mutation in the United Kingdom were invited to participate in a study of neurocognitive and neuroimaging phenotypes.

resultsSeven out of nine males with ZDHHC9 mutations had been diagnosed with epilepsy, exceeding epilepsy risk in XLID comparison subjects (P = 0.01). Seizure histories and EEG features amongst ZDHHC9 mutation cases shared characteristics with rolandic epilepsy (RE). Specific cognitive deficits differentiated males with ZDHHC9 mutations from XLID comparison subjects and converged with reported linguistic and nonlinguistic deficits in idiopathic RE: impaired oromotor control, reduced verbal fluency, and impaired inhibitory control on visual attention tasks. Consistent neuroanatomical abnormalities included thalamic and striatal volume reductions and hypoplasia of the corpus callosum.

interpretationMutations in ZDHHC9 are associated with susceptibility to focal seizures and specific cognitive impairments intersecting with the RE spectrum. Neurocognitive deficits are accompanied by consistent abnormalities of subcortical structures and inter-hemispheric connectivity. The biochemical, cellular and network-level mechanisms responsible for the ZDHHC9-associated neurocognitive phenotype may be relevant to cognitive outcomes in RE.

Identifiers

PMID26000327
PMCPMC4435709
OpenAlexW2006895076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.